Crossmark

ASO Visual Abstract: Ileocecal and Small-Bowel Involvement are Independently Associated with Inferior Survival Despite Complete Cytoreduction in FIGO IIIC–IV Tubo-Ovarian and Primary Peritoneal Carcinoma

Crossref DOI link: https://doi.org/10.1245/s10434-026-19606-0

Published Online: 2026-04-27

Published Print: 2026-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Runnebaum, Ingo B.

Kather, Angela

Goerdt, Clara Evangelia

Nguyen, Huyen Thi Thanh

Bokhua, Davit
License Information

Text and Data Mining valid from 2026-04-27

Version of Record valid from 2026-04-27
More Information

Article History

First Online: 27 April 2026

Disclosure

: IBR is a founding member of the Ovarian Tumor Committee of the German Gynecologic Oncology Group (AGO) and member of the author team releasing the national ‘S3 Guideline on Diagnosis, Treatment, and Follow-up of Malignant Ovarian Tumors.’ IBR is Chief Executive Officer and shareholder of RU21 GmbH (r-u-21.com ); RU21 GmbH develops and produces longevity health products unrelated to thepresent study. The other authors declare no conflicts of interest.

: This study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of the Jena University Hospital (no. 2021-2262-Daten on 09.06.2021).

Document is current

Any future updates will be listed below